focus -WSS

focus

author：knowledge 2025-09-14 21:55:22 - browse：56

Teleflex announced plans on Wednesday to acquire Palette Life Sciences, the maker of a slate of gel-based products treating urological disorders. The vascular device manufacturer will pay $600 million upfront, and plans to use Palette’s portfolio to treat more urinary tract and reproductive health conditions.

Palette will bring Teleflex an extra $56 million in sales, the company estimated in a press release. Teleflex develops a range of devices, but makes the most money from vascular products like catheters. The company offers just one urological treatment: the UroLift system to relieve an enlarged prostate. With Palette, it will gain five more treatments all built from hyaluronic acid, a stretchy material that’s meant to last longer in the human body.

Palette’s highest-revenue device is Barrigel, which helps protect the rectum from harsh radiation administered to prostate cancer patients. It eases symptoms like bladder inflammation, bleeding, and diarrhea. The device received FDA clearance in May 2022 through the 510(k) process, which allowed Palette to claim the product was equivalent to a rectal radiation protector sold by Boston Scientific. Boston Scientific has sold that device since 2018, when it acquired it by buying the startup Augmenix for $500 million.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： Editas, Vertex strike deal on CRISPR

WSS

David Ricks of Eli Lilly: best biopharma CEO of 2023

Inaction leaves children at risk from dangerous chemotherapy drug

Keeping primary care docs in field isn't impossible, says AAFP CEO

Carvykti CAR

Sanofi to acquire U.S. biotech Inhibrx in $2.2 billion deal

Humana’s Medicare Advantage lawsuit should be tossed, DOJ says

leisure time

focus

explore

DIEP, the 'gold standard' of breast reconstruction, is under threat

Virtual care provider acquires bankrupt Pear's prescription apps

Trump demands the U.S. pay no more for drugs than other countries … again

Readout Newsletter: The latest on Moderna, Apellis, and Merck

Apple is now the first public company to be valued at $3 trillion

Head of FDA's diagnostics center, who led through Covid, retires

ChatGPT in medicine: STAT answers readers' burning questions

Head of FDA's diagnostics center, who led through Covid, retires

Jerome Adams on the need for new antivirals for Covid

Editas, Vertex strike deal on CRISPR

Wikipedia

HCA sued by state AG for quality issues at Mission Health

High breast density mammograms need follow

In Spain, a hospital brews its own CAR

Sanofi to acquire U.S. biotech Inhibrx in $2.2 billion deal

High breast density mammograms need follow

To bolster infectious disease surveillance, genomics powerhouses team up

Wikipedia

knowledge

knowledge

leisure time